...
首页> 外文期刊>Journal of Oncology Practice >Oncologists' and Primary Care Physicians' Awareness of Late and Long-Term Effects of Chemotherapy: Implications for Care of the Growing Population of Survivors
【24h】

Oncologists' and Primary Care Physicians' Awareness of Late and Long-Term Effects of Chemotherapy: Implications for Care of the Growing Population of Survivors

机译:肿瘤科医生和初级保健医师对化疗的近期和长期影响的认识:对不断增长的幸存者的护理意义

获取原文
   

获取外文期刊封面封底 >>

       

摘要

AbstractBecause primary care providers may not be directly exposed to chemotherapy-related late effects, oncologists must communicate this information to primary care providers as patients transition to primary care settings. Purpose: The population of cancer survivors is large and growing. Yet after successful completion of treatment, many experience chemotherapy-related late or long-term effects (LEs). The extent to which physicians are aware of LEs is unknown. Methods: We conducted a nationally representative survey of 1,130 oncologists and 1,072 primary care providers (PCPs). Respondents were asked to select the LEs they had either observed or seen reported for five chemotherapy agents used to treat breast and colon cancers. We described and compared oncologists' and PCPs' awareness of the specified LEs. Using multivariate logistic regression models, we determined predictors of physicians' awareness of the main LEs associated with the agents. Results: Almost all oncologists (95%) reported awareness of cardiac dysfunction as an LE of doxorubicin and peripheral neuropathy as an LE of paclitaxel (97%) and oxaliplatin (97%). These LEs were reported by 55%, 27%, and 22% of PCPs, respectively. Most oncologists reported awareness of premature menopause (71%) and secondary malignancies (62%) as LEs of cyclophosphamide, compared with only 15% and 17% of PCPs, respectively. Main LEs associated with all four agents were identified by 65% of oncologists and only 6% of PCPs. Conclusion: Although more than half of PCPs were aware of cardiac dysfunction as an LE of doxorubicin, awareness of other LEs was limited. Because PCPs may not be directly exposed to chemotherapy-related LEs, oncologists must communicate this information to PCPs as patients transition to primary care settings. Education for all providers caring for the growing population of cancer survivors is needed.
机译:摘要由于初级保健提供者可能不会直接暴露于与化疗相关的后期影响,因此肿瘤学家必须在患者过渡到初级保健设置时将此信息告知初级保健提供者。目的:癌症幸存者的人数庞大且正在增长。然而,成功完成治疗后,许多人会经历与化疗相关的晚期或长期效应(LEs)。医师了解LE的程度尚不清楚。方法:我们对1,130名肿瘤学家和1,072名初级保健提供者(PCP)进行了全国代表性的调查。要求受访者选择用​​于治疗乳腺癌和结肠癌的五种化学疗法药物所观察到或所报道的LE。我们描述并比较了肿瘤学家和PCP对指定LE的认识。使用多元逻辑回归模型,我们确定了医师对与这些药物相关的主要LE的认识的预测因子。结果:几乎所有的肿瘤科医生(95%)都报告了对心脏功能障碍的认识是阿霉素的LE,而周围神经病则是紫杉醇(97%)和奥沙利铂(97%)的LE。据报告,这些LE分别占PCP的55%,27%和22%。大多数肿瘤学家报告说,人们对环磷酰胺的LE认识到更年期更早(71%)和继发性恶性肿瘤(62%),而PCP分别仅为15%和17%。 65%的肿瘤科医生和6%的PCPs确定了与所有4种药物相关的主要LE。结论:尽管有一半以上的PCP都知道心脏功能障碍是阿霉素的LE,但对其他LE的认识有限。由于PCP可能不会直接暴露于与化疗相关的LE,因此在患者过渡到初级保健机构时,肿瘤科医生必须将此信息传达给PCP。需要对所有照顾癌症幸存者人数不断增加的提供者进行教育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号